Abstract. Receptors for granulocyte-macrophage colonystimulating factor (GM-CSF) and interleukin-3 (IL-3) share a common ß subunit. We recently reported that GM-CSF acts in concert with transforming growth factor-ß1 (TGF-ß1) and Notch ligand Delta-1 (Delta-1) to promote the differentiation of human blood monocytes into Langerhans cells. In the present study, we examined whether IL-3, in place of GM-CSF, can induce the development of Langerhans cells from blood monocytes in the presence of TGF-ß1 and Delta-1, because the IL-3 receptor · chain was substantially expressed on monocytes. However, the generation of Langerhans cells was not obtained by the combination of IL-3, TGF-ß1 and Delta-1, even though GM-CSF and IL-3 exhibited a similar effect with respect to the differentiation of monocytes into macrophages and dendritic cells. The addition of GM-CSF to the culture supplemented with IL-3, TGF-ß1 and Delta-1 restored the differentiation of monocytes toward Langerhans cells. A microarray analysis revealed that a number of genes including Langerhans cell markers, E-cadherin and Langerin, were specifically expressed in cells from GM-CSF-containing cultures but not in those from IL-3-containing cultures. These data suggest that IL-3 can not replace GM-CSF to induce the differentiation of human monocytes into Langerhans cells in culture.
Introduction
The differentiation and proliferation of hematopoietic cells are at least in part regulated by hematopoietic growth factors that serve a variety of functions by interacting with their receptors (1) (2) (3) (4) . Among these growth factors, granulocyte-macrophage colony-stimulating factor (GM-CSF), interleukin-3 (IL-3) and IL-5 display similar biologic activities and cross-competition as well as distinct activities, depending on the type of target cells (5) . Receptors for GM-CSF, IL-3 and IL-5 are heterodimers composed of two subunits: a unique · chain and a common ß (ßc) chain. The · chain binds to each cytokine with a low affinity. The binding of a cytokine to its · chain leads to cross-linking with the ßc chain, thereby forming the high-affinity receptors. The association between the · and ßc chains is required for signal transduction. As these subunits lack intrinsic tyrosine kinase domains, tyrosine kinases that are closely associated with the receptors seem to be activated for the intracellular transmission of their signals. Overlapping biologic activities result from the signal events mediated through the ßc receptor component, whereas the cytokinespecific responses elicited by these cytokines are dependent on the distribution of their specific · chain receptor component.
Monocytes are a population of leukocytes that originate in the bone marrow and enter the peripheral blood as nondividing cells (6) . Subsequently, they migrate from the bloodstream into various peripheral tissues in response to various stimuli. During this process, they undergo terminal differentiation to become macrophages. Both · chain receptor components for GM-CSF and IL-3 are expressed in human monocytes (7) . Monocytes differentiate into macrophages upon in vitro culture with GM-CSF or IL-3 (5, 8) . GM-CSF in combination with IL-4 promotes the differentiation of peripheral blood monocytes into immature dendritic cells (DCs) (9) (10) (11) . The culturing of monocytes with IL-3 and IL-4 gives rise to cells with the morphologic, phenotypic, and immunostimulatory features of monocyte-derived DCs (12) . Since biologic activities of GM-CSF on human monocytes overlap substantially with those of IL-3, it is likely that signal events mediated through the ßc chain are responsible for the actions of GM-CSF and IL-3 on monocytes.
Recently, we found that GM-CSF, transforming growth factor-ß1 (TGF-ß1), and Notch ligand Delta-1, all of which are synthesized in the milieu of the skin, induce the differentiation of human blood monocytes into Langerhans cells (13) . As previous studies have demonstrated similar activities of GM-CSF and IL-3 on human blood monocytes (5,12), we investigated whether IL-3 can replace GM-CSF Cytokines and reagents. The immobilized extracellular domain of Delta-1 was used as Notch ligand Delta-1. The extracellular domain of Delta-1 with 6 myc-tags (Delta-1 ext-myc ) was prepared, as previously described (14, 15) . Delta-1 ext-myc (1 μg/ml) was immobilized on the 24-well tissue culture plates (Nunc, Roskilde, Denmark) that were incubated with F(ab') 2 fragments of a mouse anti-myc antibody, 9E10, at the concentration of 5 μg/ml for 30 min at 37˚C. The culture plates were washed with 0.1% BSA PBS. Delta-1 ext-myc and 9E10 were gifts from Dr I.D. Bernstein (Fred Hutchinson Cancer Research Center, Seattle, WA, USA). Recombinant human GM-CSF and IL-3 were gifts from Kirin Brewery (Tokyo, Japan). Recombinant IL-4 was purchased from Genzyme (Cambridge, MA, USA). Recombinant human TGF-ß1 was purchased from R&D Systems (Minneapolis, MN, USA). The concentrations of the cytokines used in this study were as follows: GM-CSF, 10 ng/ml; IL-3, 10 ng/ml; IL-4, 10 ng/ml; TGF-ß1, 10 ng/ml.
Culture. RPMI-1640 culture medium (Nissui Pharmaceutical, Tokyo, Japan) was supplemented with 2 mM L-glutamine, 50 U/ml penicillin, 50 μg/ml streptomycin and 10% fetal bovine serum (FBS) (HyClone Laboratories, Logan, UT, USA). CD14 + cells (5x10 5 /ml) were seeded in the 24-well tissue culture plates with designated combinations of cytokines for 7 days. Half of the culture medium was removed and replaced with fresh medium with cytokines on day 3 or 4.
Flow cytometry. Flow cytometry was performed using a FACSCalibur flow cytometer. The data were analyzed using CellQuest software (BD Biosciences, San Jose, CA, USA). For membrane staining, freshly isolated and cultured cells were stained with monoclonal antibodies (mAbs) for 30 min on ice and then they were washed three times with 0.1% BSA PBS. The cells were resuspended in 0.1% BSA PBS containing 1 μg/ml propidium iodide and incubated in the dark for 10 min at room temperature, in order to exclude dead cells from the analysis. An intracellular molecule was stained using the Cytofix/Cytoperm kit (BD Biosciences Pharmingen, San Diego, CA, USA). The cells were fixed for 20 min at 4˚C with formaldehyde-based fixation medium. After washing twice with PBS, the cells were resuspended in the permeabilization buffer and stained with mAb. PBS containing Ca 2+ was used instead of PBS for staining of E-cadherin. The following murine mAbs were used: fluorescein isothio- Microarray. Microarray assay was carried out as described with some modifications (16, 17) . Double-stranded cDNA was synthesized from total RNA extracted from each sample by the acid guanidinium method, using the One-Cycle cDNA Synthesis kit (Affymetrix, Santa Clara, CA, USA). Biotinlabeled cRNA was prepared from each cDNA by 3'-amplification reagents for the IVT labeling kit (Affymetrix), and hybridized to a GeneChip Human Genome U133A Plus 2.0 array (Affymetrix) harboring >45,000 human probe sets. Hybridization, washing and detection of signals on the arrays were performed using the GeneChip System (Affymetrix), according to standard protocols provided by the manufacturer. The fluorescence intensity for each gene was normalized, based on the median expression value of the positive control genes (Affymetrix; HGU133Anorm.MSK) in each hybridization. Every microarray analysis was repeated twice. Hierarchical clustering of the data set was conducted using the Gene Spring software version 7.2 (Aglilent Technologies, Palo Alto, CA, USA). Statistical analysis was performed using the Student's t-test.
Results

Blood monocytes become macrophages in response to GM-CSF and IL-3.
We analyzed the expression of GM-CSFR· and IL-3R· on peripheral blood CD14 + monocytes (Fig. 1) . Monocytes displayed high and moderate levels of GM-CSFR· and IL-3R·, respectively, on their cell surface, consistent with previous reports (7, 18) . We cultured CD14 + monocytes in the presence of GM-CSF and then evaluated the phenotype of the cultured cells on day 7 of incubation ( Fig. 2) . The cultured cells were positive for CD14, CD16, CD11c and M-CSFR but negative for CD1a and MPO. Culture of CD14 + cells cultured with IL-3 plus IL-4 was analyzed on day 7 of incubation, the cells displayed high levels of CD1a, HLA-ABC, HLA-DR, CD40 and CD11c. They expressed CD54, CD80, CD86, and DC-SIGN but did not bear CD16 or CD14 (Fig. 3) . These profiles are consistent with those of DCs generated from CD14 + cells with GM-CSF plus IL-4 as a comparison, although a small difference was observed in the expression level of CD1a, in accordance with a previous report (18) . These data indicate that GM-CSF and IL-3 thus exert virtually similar activities on blood monocytes in the differentiation pathway toward DCs as well as macrophages. and Delta-1. Our recent study reported that GM-CSF, in concert with TGF-ß1 and Delta-1, promotes the differentiation of monocytes into Langerhans cells, as characterized by the expression of CLA, CCR6, Langerin and E-cadherin (13) . They also express CD1a, HLA-ABC, HLA-DR, CD80, CD86, CD40, CD54 and CD11c. We, therefore, investigated whether monocytes differentiate into Langerhans cells in the presence of IL-3, TGF-ß1 and Delta-1 instead of GM-CSF, TGF-ß1 and Delta-1 (Fig. 4) . In contrast to CD14 + monocytes cultured in the presence of GM-CSF, TGF-ß1 and Delta-1, the cells obtained from culture with IL-3, TGF-ß1 and Delta-1 were negative for CLA, CCR6, Langerin and E-cadherin. These cells retained HLA-ABC, HLA-DR, CD40, CD54 and CD11c, while remaining negative for DC-SIGN. The expression level of CD1a, CD80 and CD86 declined, while CD14 was expressed. Therefore, IL-3 and GM-CSF most likely have a distinct effect on monocytes in the presence of TGF-ß1 and Delta-1. We next added both GM-CSF and IL-3 to the cultures supplemented with TGF-ß1 and Delta-1. The cultured cells exhibited a phenotype similar to that observed with cultures containing GM-CSF, TGF-ß1 and Delta-1.
GM-CSF but not IL-3 induces the differentiation of blood monocytes into Langerhans cells in the presence of TGF-ß1
Gene expression profiles of CD14 + monocytes cultured with GM-CSF, TGF-ß1 and Delta-1 or with IL-3, TGF-ß1 and Delta-1. The cells generated from CD14
+ monocytes with IL-3, TGF-ß1 and Delta-1 appear to be phenotypically distinctive from those with GM-CSF, TGF-ß1 and Delta-1. In an attempt to distinguish between these two cell groups, we performed gene expression profiling. To facilitate comparison of each group, we analyzed the 6 expression data sets of the cells cultured with GM-CSF, TGF-ß1 and Delta-1 (n=2), those with IL-3, TGF-ß1 and Delta-1 (n=2) and freshly isolated CD14 + monocytes (n=2) (Fig. 5) and identified the genes which were differentially expressed between the former 2 groups. We first searched for the genes with expression levels more than 100 times higher in the cells cultured with GM-CSF, TGF-ß1 and Delta-1 than those cultured with IL-3, TGF-ß1 and Delta-1. Table I shows the genes whose expression was significantly different in the 2 groups (Student's t-test, P<0.05). The well-known cell surface antigens for Langerhans cells, E-cadherin (gene symbol CDH1; GenBank accession no. NM 004360) and Langerin (gene symbol CD207; GenBank accession no. NM 015717), were abundantly expressed in the cells cultured with GM-CSF, TGF-ß1 and Delta-1. In contrast, we did not detect the genes that were expressed more than 100-fold in cells cultured with IL-3, TGF-ß1 and Delta-1, in comparison to the cells cultured with GM-CSF, Figure 4 . Phenotype of CD14 + monocytes cultured in the presence of GM-CSF + TGF-ß1 + Delta-1, IL-3 + TGF-ß1 + Delta-1 or GM-CSF + IL-3 + TGF-ß1 + Delta-1. CD14 + monocytes (5x10 5 /ml) were cultured for 7 days. The expression of CD1a, CLA, CCR6, Langerin, E-cadherin, HLA-ABC, HLA-DR, CD80, CD86, CD40, CD54, CD11c, DC-SIGN, CD16 and CD14 was analyzed using a FACSCalibur flow cytometer. The thick and thin lines represent the expression of the indicated molecules and isotype controls, respectively. Similar results were obtained with 3 different donors.
TGF-ß1 and Delta-1. These data support the notion that IL-3 and GM-CSF act on monocytes in a different manner in the presence of TGF-ß1 and Delta-1.
Discussion
The receptor complexes for GM-CSF and IL-3 consist of a cytokine-specific · subunit and a ßc subunit (5) . The ßc subunit is important for signal transduction. Our objective in this study was to determine whether IL-3 could function in the same manner as GM-CSF for the generation of Langerhans cells from CD14 + peripheral blood monocytes in the presence of TGF-ß1 and Notch ligand Delta-1. Our data show that IL-3 did not induce Langerhans development from blood monocytes. This finding indicates that GM-CSF is essential for the development of Langerhans cells from human blood monocytes. The GM-CSF-specific · subunit may deliver the signals to monocytes for their Langerhans cell development. This notion is supported by our observation that the further addition of GM-CSF to the cultures containing IL-3, TGF-ß1 and Delta-1 allowed monocytes to differentiate into Langerhans cells. Previous studies reported that none of the GM-CSF null and GM-CSF receptor ß chain null mice lacked epidermal Langerhans cells (19, 20) . This demonstrates that GM-CSF does not have a selective effect on the development of Langerhans cells in vivo in mice. GM-CSF may be differentially required for Langerhans cell development between mice and humans. Inconsistent with our present study, Caux et al (21) reported that in cooperation with TNF-·, IL-3 is similarly potent in generating dendric Langerhans cells from human cord blood CD34 + hematopoietic progenitor in comparison to GM-CSF. It is likely that the common ß chain-mediated signals elicited by GM-CSF or IL-3 play a pivotal role in the development of Langerhans cells from hematopoietic progenitor cells but not from blood monocytes.
It is generally accepted that GM-CSF and IL-3 induce the differentiation of monocytes into macrophages. As expected, our data obtained from a phenotypic analysis also supported this idea. When monocytes were cultured with GM-CSF or IL-3 in the presence of IL-4, the resulting cells from both cultures exhibited the phenotype of DCs with the minor exception of the expression pattern of CD1a. These findings suggest that the signals mediated through the ßc chain of GM-CSF and IL-3 receptors are mainly involved in the differentiation process of monocytes into macrophages and DCs, which may be different in the case of Langerhans cell development from monocytes.
Interestingly, our microarray analysis indicated that although there existed a small subset of genes whose transcripts were significantly up-regulated in the cells cultured with GM-CSF, TGF-ß1 and Delta-1 in comparison to those with IL-3, TGF-ß1 and Delta-1, there were no genes that were more than 100-fold up-regulated in the cells cultured with IL-3, TGF-ß1 and Delta-1. It may be speculated that the cells obtained from cultures with IL-3, TGF-ß1 and Delta-1 are intermediate between monocytes and Langerhans cells, in terms of their gene expression. It is also interesting to note that the subset of genes that were more abundantly expressed in the cells cultured with GM-CSF, TGF-ß1 and Delta-1 Figure 5 . Expression profiles of genes specific for the cells cultured with GM-CSF + TGF-ß1 + Delta-1, for those with IL-3 + TGF-ß1 + Delta-1 and for freshly isolated CD14 + monocytes. The gene tree was constructed using 2-way clustering analysis of the genes whose expression is different among cells cultured with GM-CSF + TGF-ß1 + Delta-1, those with IL-3 + TGF-ß1 + Delta-1 and freshly isolated CD14 + monocytes. Each row indicates a single gene on the microarray, and each column indicates a separate donor sample. The expression intensity of each gene is color-coded, according to the scale at the bottom right. Table I . Genes with a statistically high expression in cells cultured with GM-CSF + TGF-ß1 + Delta-1. 
included E-cadherin and Langerin which are Langerhans cell markers. In this context, it is relevant that the signals mediated through the GM-CSF-specific · chain are indispensable for the induction of Langerhans cells from monocytes. Consequently, we considered that it would be interesting to examine whether or not a selective block of the GM-CSF receptor · chain suppresses the differentiation of monocytes into Langerhans cells in the presence of GM-CSF, IL-3, TGF-ß1 and Delta-1. However, even though we used several anti-GM-CSF receptor · chain neutralizing mAbs, they failed to inhibit the Langerhans cell development from monocytes (data not shown). At present, no likely explanation can be provided for this failure. Further studies are required to address this issue.
An earlier study has shown that human cord blood CD34 + hematopoietic progenitor cells generate CD14 -precursors which give rise to Langerhans cells (22) . We observed that CD14 + monocytes which are derived from CD34 + hematopoietic progenitor cells differentiate into Langerhans cells, in agreement with previous reports that demonstrate the generation of Langerhans cells from CD14 + blood monocytes (23, 24) . These results may therefore represent two distinct differentiation pathways from CD34 + hematopoietic progenitor cells toward Langerhans cells.
GM-CSF and TGF-ß1 are produced by keratinocytes (25) (26) (27) . Delta-1 is expressed by epidermal stem cells which are surrounded by keratinocytes (28) . The constitutive expression of IL-3 is not detected in normal cells. The cellular source of IL-3 is restricted to activated T cells (29, 30) . Together with these findings, our data emphasize the importance of the skin cytokine environment in the development of Langerhans cells from blood monocytes.
